Amanda Elmore

Amanda Elmore
  • Doctor of Philosophy
  • Maternal and Child Health Assistant Professor at University of South Florida

About

18
Publications
1,495
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
345
Citations
Introduction
Tenure-track Maternal and Child Health Assistant Professor at the University of South Florida College of Public Health. My research focuses on reproductive, perinatal, and pediatric epidemiology with a centering theme of how social determinants of health, adverse childhood experiences (ACEs), and trauma influence health outcomes at each stage of life for the mother-infant dyad.
Current institution
University of South Florida
Current position
  • Maternal and Child Health Assistant Professor
Additional affiliations
January 2021 - August 2022
Florida State University
Position
  • Adjunct Faculty
January 2017 - December 2022
Florida Department of Health
Position
  • Birth Defect Epidemiologist
Description
  • Epidemiologist with the Florida Birth Defects Registry tasked with surveillance of birth defects and neonatal abstinence syndrome (NAS).
August 2018 - August 2022
University of South Carolina
Position
  • PhD Student
Description
  • NIH T32 Predoctoral fellow completing PhD in Epidemiology
Education
August 2018 - May 2022
University of South Carolina
Field of study
  • Epidemiology
August 2015 - May 2017
Florida State University
Field of study
  • Public Health
August 2010 - December 2014
University of Kentucky
Field of study
  • Medical Laboratory Sciences

Publications

Publications (18)
Article
Background Surveillance of birth defects is critical to track prevalence and inform prevention efforts. Previous studies suggest that restricting abortion may lead to an increase in birth defect prevalence. However, it is unclear how abortion legislation will impact birth defect prevalence estimates reported by state‐based surveillance programs. M...
Article
Full-text available
OBJECTIVE To evaluate access to prenatal care for pregnant patients receiving medication for opioid use disorder (MOUD) under Medicaid coverage in Florida. METHODS A cross-sectional, secret shopper study was conducted in which calls were made to randomly selected obstetric clinicians' offices in Florida. Callers posed as a 14-week-pregnant patient...
Article
Background: To characterize neurodevelopmental abnormalities in children up to 36 months of age with congenital Zika virus exposure. Methods: From the U.S. Zika Pregnancy and Infant Registry, a national surveillance system to monitor pregnancies with laboratory evidence of Zika virus infection, pregnancy outcomes and presence of Zika associated...
Article
Full-text available
Objectives: Studies have shown significant increases in the prevalence of maternal opioid use. Most prevalence estimates are based on unverified ICD-10-CM diagnoses. This study determined the accuracy of ICD-10-CM opioid-related diagnosis codes documented during delivery and examined potential associations between maternal/hospital characteristics...
Article
Full-text available
Introduction: Opioid use disorder (OUD) remains prevalent. Medications for OUD (MOUD) are standard care for pregnant and non-pregnant women. Previous research has identified barriers to MOUD for women with Medicaid but did not account for the type of MOUD (methadone vs. buprenorphine) or pregnancy status. We examined access to MOUD by treatment ty...
Preprint
Full-text available
Background To characterize neurodevelopmental abnormalities in children up to 36 months of age with congenital Zika virus exposure. Methods From the U.S. Zika Pregnancy and Infant Registry, a national surveillance system to monitor pregnancies with laboratory evidence of Zika virus infection, pregnancy outcomes and presence of Zika associated birt...
Preprint
Full-text available
Background To characterize neurodevelopmental abnormalities in children up to 36 months of age with congenital Zika virus exposure. Methods From the U.S. Zika Pregnancy and Infant Registry, a national surveillance system to monitor pregnancies with laboratory evidence of Zika virus infection, pregnancy outcomes and presence of Zika associated birt...
Article
Full-text available
During the Centers for Disease Control and Prevention's Zika Virus Response, birth defects surveillance programs adapted to monitor birth defects potentially related to Zika virus (ZIKV) infection during pregnancy. Pregnancy outcomes occurring during January 2016 to June 2017 in 22 U.S. states and territories were used to estimate the prevalence of...
Article
Zika virus infection during pregnancy can cause serious birth defects of the brain and eyes, including intracranial calcifications, cerebral or cortical atrophy, chorioretinal abnormalities, and optic nerve abnormalities (1,2). The frequency of these Zika-associated brain and eye defects, based on data from the U.S. Zika Pregnancy and Infant Regist...
Preprint
Full-text available
During the Centers for Disease Control and Prevention’s Zika Virus Response, birth defects surveillance programs adapted to monitor birth defects potentially related to Zika virus (ZIKV) infection during pregnancy. Pregnancy outcomes occurring during January 2016-June 2017 in 22 U.S. states and territories were used to estimate the prevalence of th...
Article
Full-text available
Women are prescribed opioids more often than men. Prescription opioid use among women of reproductive age is a public health concern because opioid use during pregnancy is associated with decreased prenatal care and increased risk of adverse perinatal and maternal outcomes. Recent prevalence estimates and correlates of prescription opioid use and l...
Article
Full-text available
BACKGROUND AND OBJECTIVES: The increase in neonatal abstinence syndrome (NAS) has underscored the need for NAS surveillance programs, but many rely on passive surveillance using unverified diagnosis codes. Few studies have evaluated the validity of these codes, and no study has assessed the recently proposed Council of State and Territorial Epidemi...
Article
Full-text available
Background Adverse childhood experiences (ACEs) are common among children. Little is known on how resilience factors and positive childhood experiences (PCEs) may moderate the relationship between ACEs and childhood depression. Objective Our study fills this gap by providing recent, nationally representative estimates of ACE and PCE exposure for a...
Article
Full-text available
Objective To determine the prevalence of anxiety and depression and examine their association with adverse childhood experiences (ACEs) among children and adolescents ages 8-17 years old. Methods Using data from the 2016-2017 National Survey of Children's Health (NSCH), we conducted a cross-sectional study design with a total sample of 39,929. Ou...
Article
Full-text available
Zika virus infection during pregnancy can cause congenital brain and eye abnormalities and is associated with neurodevelopmental abnormalities (1-3). In areas of the United States that experienced local Zika virus transmission, the prevalence of birth defects potentially related to Zika virus infection during pregnancy increased in the second half...

Network

Cited By